Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.70 |
| ▸ | MEN1 | O00255 | 3/20 | 0.70 |
| ▸ | MAPT | P10636 | 2/20 | 0.70 |
| ▸ | LMNA | P02545 | 1/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.69 |
| ▸ | NLRP3 | Q96P20 | 11/20 | 0.67 |
| ▸ | HTT | P42858 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridine SCHEMBL5157631 | 0.92 | ALDH1A1 (0.67) | GAAKMT2AMEN1MAPTLMNA | |
| SCHEMBL6754266 | 0.82 | ALDH1A1 (1.00) | GAAKMT2AMEN1MAPTLMNA | |
| SCHEMBL7244275 | 0.81 | GAA (0.69) | GAAKMT2AMEN1MAPTLMNA | |
| SCHEMBL29520161 | 0.81 | NLRP3 (0.75) | KMT2AMEN1MAPTLMNAALDH1A1 | |
| SCHEMBL4423342 | 0.81 | NLRP3 (0.75) | KMT2AMEN1MAPTLMNAALDH1A1 | |
| SCHEMBL709156 | 0.80 | MEN1 (0.70) | GAAKMT2AMEN1MAPTALDH1A1 | |
| SCHEMBL4628679 | 0.80 | KMT2A (0.71) | GAAKMT2AMEN1MAPTLMNA | |
| SCHEMBL27841700 | 0.79 | MEN1 (0.74) | GAAKMT2AMEN1MAPTLMNA | |
| SCHEMBL28851551 | 0.78 | NLRP3 (0.67) | KMT2AMEN1NLRP3 | |
| SCHEMBL10052144 | 0.78 | NLRP3 (0.70) | KMT2AMEN1MAPTALDH1A1NLRP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8101655-B2 | Fluorescent dyes and complexes | SMITH GERALD ARTHUR (GB) | 2012-01-24 | — | — | US | disclosed |
| US-8101655-B2 | Fluorescent dyes and complexes | SMITH GERALD ARTHUR (GB) | 2012-01-24 | — | — | US | disclosed |
| US-20100256399-A1 | FLUORESCENT DYES AND COMPLEXES | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2010-10-07 | — | — | US | disclosed |
| US-20100256399-A1 | FLUORESCENT DYES AND COMPLEXES | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2010-10-07 | — | — | US | disclosed |
| US-7674918-B2 | Fluorescent dyes and complexes | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2010-03-09 | — | — | US | disclosed |
| US-7674918-B2 | Fluorescent dyes and complexes | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2010-03-09 | — | — | US | disclosed |
| US-20070238884-A1 | Fluorescent Dyes and Complexes | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2007-10-11 | — | — | US | disclosed |
| US-20070238884-A1 | Fluorescent Dyes and Complexes | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2007-10-11 | — | — | US | disclosed |
| US-20070238884-A1 | Fluorescent Dyes and Complexes | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2007-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070238884-A1 | Fluorescent Dyes and Complexes | F12, PYM1, ANXA6 | GAA 3000/4885KMT2A 4230/4885MEN1 3023/4885 |
| US-20100256399-A1 | FLUORESCENT DYES AND COMPLEXES | F12, ANXA6, PYM1 | GAA 3335/4885KMT2A 4351/4885MEN1 2188/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.